NARLAPREVIR

UNII:	2857LA2O07
Formula:	C₃₆H₆₁N₅O₇S
Preferred Substance Name:	NARLAPREVIR
InChIKey:	RICZEKWVNZFTNZ-LFGITCQGSA-N

865466-24-6
(1R,2S,5S)-3-(N-(((1-((TERT-BUTYLSULFONYL)METHYL)CYCLOHEXYL)AMINO)CARBONYL)-3-METHYL-L- VALYL)-N-((1S)-1-((CYCLOPROPYLAMINO)(OXO)ACETYL)PENTYL)-6,6-DIMETHYL-3- AZABICYCLO(3.1.0)HEXANE-2-CARBOXAMIDE
(1R,2S,5S)-N-((1S)-1-(2-(CYCLOPROPYLAMINO)-2-OXOACETYL)PENTYL)-3-((2S)-2-(((1-(((1,1- DIMETHYLETHYL)SULFONYL)METHYL)CYCLOHEXYL)CARBAMOYL)AMINO)-3,3-DIMETHYLBUTANOYL)-6,6- DIMETHYL-3-AZABICYCLO(3.1.0)HEXANE-2-CARBOXAMIDE
3-AZABICYCLO(3.1.0)HEXANE-2-CARBOXAMIDE, N-((1S)-1-(2-(CYCLOPROPYLAMINO)-2- OXOACETYL)PENTYL)-3-((2S)-2-((((1-(((1,1-DIMETHYLETHYL)SULFONYL)METHYL)CYCLOHEXYL) AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-, (1R,2S,5S)-
NARLAPREVIR [INN]
NARLAPREVIR [USAN]
NARLAPREVIR [WHO-DD]
SCH 900518
SCH-900518

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NARLAPREVIR

Synonyms and Mappings

Resources